These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 18198195
1. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM. Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195 [Abstract] [Full Text] [Related]
2. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study. Zandbelt MM, de Wilde P, van Damme P, Hoyng CB, van de Putte L, van den Hoogen F. J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226 [Abstract] [Full Text] [Related]
14. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F. Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600 [Abstract] [Full Text] [Related]
18. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST. Thorax; 2005 Dec; 60(12):1012-8. PubMed ID: 16166100 [Abstract] [Full Text] [Related]
19. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis. Pang L, Wang L, Suo T, Hao H, Fang X, Jia J, Huang F, Tang J. J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053 [Abstract] [Full Text] [Related]